Discontinued — last reported Q4 '25
Norfolk Southern Interest Paid decreased by 5.1% to $185.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.6%, from $192.00M to $185.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 7.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $171.00M | $110.00M | $188.00M | $114.00M | $180.00M | $131.00M | $194.00M | $129.00M | $189.00M | $133.00M | $202.00M | $182.00M | $191.00M | $198.00M | $193.00M | $192.00M | $186.00M | $192.00M | $195.00M | $185.00M |
| QoQ Change | — | -35.7% | +70.9% | -39.4% | +57.9% | -27.2% | +48.1% | -33.5% | +46.5% | -29.6% | +51.9% | -9.9% | +4.9% | +3.7% | -2.5% | -0.5% | -3.1% | +3.2% | +1.6% | -5.1% |
| YoY Change | — | — | — | — | +5.3% | +19.1% | +3.2% | +13.2% | +5.0% | +1.5% | +4.1% | +41.1% | +1.1% | +48.9% | -4.5% | +5.5% | -2.6% | -3.0% | +1.0% | -3.6% |